Inspire Medical Systems Stock

Inspire Medical Systems Equity

The The Equity of Inspire Medical Systems (INSP) as of Aug 20, 2026 is 781.16 M USD. In the previous year, The Equity was 689.70 M USD — a change of 13.26% (higher).

Equity

781.16 MUSD

YoY

13.26%

Last updated:

In 2026, Inspire Medical Systems's equity was 781.16 M USD, a 13.26% increase from the 689.70 M USD equity in the previous year.

Access this data via the Eulerpool API

Inspire Medical Systems Stock analysis

What does Inspire Medical Systems do? Inspire Medical Systems Inc. is an American medical technology company that was founded in 2007 in Maple Grove, Minnesota. It focuses primarily on the development and production of implantable medical devices used in the treatment of sleep apnea. The company's business model is based on manufacturing and selling implantable devices, which are used by specially trained doctors. Inspire offers a comprehensive training program to educate doctors on the use of their devices and ensure optimal patient treatment. The company has had an impressive success story since its founding, with significant investments in research and development and the attainment of several patents. In summary, Inspire Medical Systems Inc. is an innovative company dedicated to the development and production of implantable medical devices for the treatment of sleep apnea. Its wide range of products and services aim to support doctors and patients, and the company is on track to become a leading provider in the industry. Inspire Medical Systems is one of the most popular companies on Eulerpool.

Equity Details

Analyzing Inspire Medical Systems's Equity

Inspire Medical Systems's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Inspire Medical Systems's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Inspire Medical Systems's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Inspire Medical Systems's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Inspire Medical Systems’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Inspire Medical Systems stock

The Equity of Inspire Medical Systems is 781.16 M USD in 2026.

The Equity of Inspire Medical Systems changed from 689.70 M USD to 781.16 M USD, representing a 13.26% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of The Equity Inspire Medical Systems since 2006 – with annual values, charts, and detailed analysis.

The Equity's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Equity's Inspire Medical Systems historically and in real time.

Access this data via the Eulerpool API

Balance Sheet — Inspire Medical Systems

All Key Metrics — Inspire Medical Systems